51. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum: A brief report.
- Author
-
Denorme P, Morren MA, Hollants S, Spaepen M, Suaer K, Zutterman N, Labarque V, Legius E, and Brems H
- Subjects
- Abnormalities, Multiple genetics, Abnormalities, Multiple therapy, Base Sequence, Bronchodilator Agents therapeutic use, Diagnosis, Differential, Enteral Nutrition, Humans, Immunosuppressive Agents therapeutic use, Infant, Newborn, Lipoma genetics, Lipoma therapy, Male, Megalencephaly genetics, Megalencephaly therapy, Musculoskeletal Abnormalities genetics, Musculoskeletal Abnormalities therapy, Mutation, Nevus genetics, Nevus therapy, Phenotype, Respiration, Artificial methods, Sirolimus therapeutic use, Skin Diseases, Vascular genetics, Skin Diseases, Vascular therapy, Telangiectasis diagnosis, Telangiectasis genetics, Telangiectasis therapy, Vascular Malformations genetics, Vascular Malformations therapy, Abnormalities, Multiple diagnosis, Class I Phosphatidylinositol 3-Kinases genetics, Lipoma diagnosis, Megalencephaly diagnosis, Musculoskeletal Abnormalities diagnosis, Nevus diagnosis, Skin Diseases, Vascular diagnosis, Telangiectasis congenital, Vascular Malformations diagnosis
- Abstract
A patient with extensive multisystem overgrowth caused by a somatic gain of function PIK3CA-mutation is described. This case is an example of the clinical diversity of the PIK3CA-Related Overgrowth Spectrum (PROS) as the patient had overlapping features of Congenital Lipomatous Overgrowth Vascular malformations Epidermal nevi and Skeletal abnormalities (CLOVES) syndrome and Megalencephaly-Capillary malformation Polymicrogyria (MCAP) syndrome and underlines the utility of this umbrella term., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF